Virus Characterization for Cell and Gene Therapy with Nano Flow Cytometry

Join us for an illuminating webinar on April 18th, 2024, and delve into the revolutionary advancements in cell and gene therapy technology!

The demand for high-purity viruses and tools for their characterization is skyrocketing with the rapid progress of cell and gene therapies. The major challenge is accurately determining the titer, structure, and contaminant levels of viral vectors throughout the development and manufacturing process. The NanoAnalzer from NanoFCM allows the multi-parameter testing of various kind of viruses, with real resolution to quantitate viral vectors in complex solutions, offering a powerful tool for cell and gene therapy industry!

Key highlights include:

  • Introduction of NanoAnalyzer and its role in comprehensive viral vector characterization.

  • Exploration about how the NanoAnalyzer swiftly detects particle size, concentration, and biochemical properties in just 1-2 minutes.

  • Understanding how NanoAnalyzer data can distinguish and quantify viral particles in complex solutions early in the production process.

  • Compelling case studies about Lentivirus from renowned cell and gene therapy players, showcasing the real-world impact of NanoFCM technology.

  • Component analysis of Adenovirus viruses by NanoAnlyzer platform.

  • Discussion of identification and quantification of extracellular vesicles, a common coisolate with viral vectors.

Plus, don't miss the live Q&A session with our speaker @Dr.Clayton Deighan. Gain insights directly from the leader of NanoFCM's applications and sales teams in North America, who brings years of expertise in characterizing single nanoparticles to researchers worldwide.


Thursday, April 18, 2024


10:00 AM EST | 7:00 AM PST | 4:00 PM CEST

Register Now

About the speaker


Dr. Clayton Deighan completed his PhD in Dr. Jeff Chalmers lab at Ohio State in 2015 and has spent the years since working with EV and viruses investigators around the world on characterization of single nanoparticles. He has now joined NanoFCM as the leader of their applications and sales teams in North America and is excited to bring their virus detection technologies to researchers around the world.